《全日總結》恆指跌312點 匯控造淡 中電信揚11%
港股今日隨外圍股市向下,恆指今早低開299點後走勢反覆,午後跌幅擴大至486點一度低見28,314點;其後跌幅有所收窄,全日跌312點或1.1%,報28,489點;國指跌98點或0.9%,報10,547點;恆生科技指數全日跌85點或1.1%,報7,955點。大市全日成交總額降至1,573.02億元。滬港通南下交易全日錄得淨流出12.74億元人民幣,深港通南下交易錄淨流入31.29億元人民幣。
匯控(00005.HK)簽訂諒解備忘,潛在出售法國零售銀行業務,全日股價跌3.5%報45.55元,摩根士丹利指匯控擬售法零售銀行料致稅前虧損23億美元略高市場預期。友邦(01299.HK)股價跌1.6%。
中電信(00728.HK)指今年派息比率不低於60%,且明年起派中期息,全日股價逆市揚11.2%收2.59元。中移動(00941.HK)、聯通(00762.HK)分別升2.7%及1.7%。
科技股偏弱,京東(09618.HK)、騰訊(00700.HK)、阿裏巴巴(09988.HK)分別跌2.2%、2.1%及0.8%,美團(03690.HK)則升0.4%。手機股小米(01810.HK)跌3%。瑞聲(02018.HK)升5.1%,舜宇(02382.HK)跌0.8%。
內需股受壓,海底撈(06862.HK)挫5.1%,同系頤海(01579.HK)亦挫7.2%。飛鶴(06186.HK)、農夫山泉(09633)分別跌7.1%及2.6%。
工行(01398.HK)、建行(00939.HK)均跌約1%。汽車股造好,吉利(00175.HK)股價升4.4%,長汽(02333.HK)彈5.1%。鞍鋼(00347.HK)預報上半年純利按年增8.6倍,全日股價揚4.3%。
生物科技股強勢,藥明生物(02269.HK)再創新高,股價全日升4%報137.4元。康龍化成(03759.HK)和方達控股(01521.HK)分別升3.8%及1.1%。
澳門計劃與本港討論縮短或減免隔離醫學觀察天數,濠賭股上揚,銀娛(00027.HK)、金沙中國(01928.HK)及永利澳門(01128.HK)分別升1.4%、2.1%及2.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.